A few days ago, researchers at West Virginia School of Medicine who are involved in the C8 Health Project provided some initial results from the 69,030 participants who live in the vicinity of DuPont’s Washington Works plant near Parkersburg, WV.  The information was presented at a May 7 public lecture entitled “The C8 Health Project: How a Class Action Lawsuit Can Interact with Public Health: History of Events” (Slides here), and was reported in the Charleston Gazette (here). 

The data to-date indicate that participants have serum concentrations of C8 (perfluorooctanoic acid (PFOA)) which are substantially higher than the general population, and these concentrations differ based on participants’ age, gender and the district in which they receive their drinking water.  Preliminary univariate analyses show associations between C8 and measures of immune, liver and thyroid function, and cholesterol levels.

The presentation prepared by the WVU researchers (with 63 slides) explains the history of the C8 Health Study, the role of the Science Panel, the WVU Project Team and Brookmar, Inc. in the project, a timeline of the legal events and study activities, as well as maps of the area from which study participants reside. 

The SKAPP website offers a case study on PFOA; a previous blog post on this topic was called “How’d that C8 get into your blood?”